Details of the Drug Formulations

General Information of Drug (ID: DMHD4PE)

Drug Name
Desvenlafaxine Drug Info
Synonyms Norvenlafaxine; Desvenlafaxine (INN); Desvenlafaxine [INN:BAN]; O-Desmethylvenlafaxine; WY 45,233; O-DESMETHYLVENLAFAXINE (ODV); WY-45,233
Indication
Disease Entry ICD 11 Status REF
Major depressive disorder 6A70.3 Approved [1]
Menopause symptom GA30.0 Phase 3 [1]
Cross-matching ID
PubChem CID
125017
ChEBI ID
CHEBI:83527
CAS Number
93413-62-8
TTD ID
D0O3FG
VARIDT ID
DR01008
ACDINA ID
D00182

Full List of Drug Formulations Containing This Drug

Desvenlafaxine 100 mg tablet
Company Formulation ID FDA Description
Par Pharmaceutical F05417 Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols
Macoven Pharmaceuticals; Pernix Therapeutics F05418 Fd&c yellow no. 6; Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols; Polyvinyl alcohol, unspecified
Sun Pharmaceutical Industries F05415 Butyl alcohol; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Shellac
Lake Eire Medical & Surgical Supply DBA Quality Care Products F05416 Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Polyvinyl alcohol; Cellulose, microcrystalline; Hypromellose 2208 (15000 mpa.s); Polyethylene glycol
Sun Pharmaceutical Industries F05414 Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Povidone k30; Alginic acid; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycol 8000
------------------------------------------------------------------------------------
Desvenlafaxine 50 mg tablet
Company Formulation ID FDA Description
Sun Pharmaceutical Industries F05420 Butyl alcohol; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Shellac
Par Pharmaceutical F05421 Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyvinyl alcohol; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols
Macoven Pharmaceuticals; Pernix Therapeutics F05422 Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Hypromellose 2208 (100000 mpa.s); Polyethylene glycols; Polyvinyl alcohol, unspecified
Sun Pharmaceutical Industries F05419 Magnesium stearate; Citric acid monohydrate; Ferric oxide red; Talc; Titanium dioxide; Polyethylene glycol 6000; Povidone k30; Alginic acid; Cellulose, microcrystalline; Hypromelloses
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7158).